Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-03-07 4:07 pm Unchanged | 2024-03-07 | 13D | Spruce Biosciences, Inc. SPRB | HealthCap VIII, L.P. | 49,142 8.900% | 0 (Unchanged) | Filing History |
| 2024-02-14 4:57 pm Sale | 2023-12-31 | 13G | Spruce Biosciences, Inc. SPRB | Citadel Advisors LLC | 1,443 0.300% | -21,855 (-93.81%) | Filing History |
| 2024-02-14 3:54 pm Purchase | 2023-12-31 | 13G | Spruce Biosciences, Inc. SPRB | Armistice Capital, LLC | 29,733 5.480% | 29,733 (New Position) | Filing History |
| 2024-02-14 2:11 pm Purchase | 2023-12-31 | 13G | Spruce Biosciences, Inc. SPRB | Rock Springs Capital Management LP | 34,788 6.410% | 13,152 (+60.79%) | Filing History |
| 2024-02-06 4:15 pm Purchase | 2023-12-31 | 13G | Spruce Biosciences, Inc. SPRB | Aisling Capital V, LP | 16,073 3.000% | 16,073 (New Position) | Filing History |
| 2024-01-30 11:06 am Purchase | 2024-01-24 | 13G | Spruce Biosciences, Inc. SPRB | Rosalind Advisors, Inc. | 30,960 5.670% | 30,960 (New Position) | Filing History |
| 2023-05-30 4:48 pm Purchase | 2023-02-16 | 13D | Spruce Biosciences, Inc. SPRB | RiverVest Venture Fund III, L.P. | 47,030 8.600% | 18,387 (+64.19%) | Filing History |
| 2023-02-27 4:00 pm Purchase | 2023-02-17 | 13G | Spruce Biosciences, Inc. SPRB | 5AM Opportunities II L.P. | 55,160 9.970% | 55,160 (New Position) | Filing History |
| 2023-02-23 4:15 pm Purchase | 2023-02-16 | 13D | Spruce Biosciences, Inc. SPRB | Carlyle Group Inc. CG | 49,794 9.200% | 25,760 (+107.18%) | Filing History |
| 2023-02-21 4:28 pm Purchase | 2023-02-16 | 13D | Spruce Biosciences, Inc. SPRB | Novo Holdings A/S | 111,711 19.900% | 51,520 (+85.59%) | Filing History |
| 2023-02-14 2:56 pm Unchanged | 2022-12-31 | 13G | Spruce Biosciences, Inc. SPRB | Rock Springs Capital Management LP | 21,636 6.890% | 0 (Unchanged) | Filing History |
| 2023-02-14 08:02 am Purchase | 2022-12-31 | 13G | Spruce Biosciences, Inc. SPRB | Citadel Advisors LLC | 23,299 7.400% | 164 (+0.71%) | Filing History |
| 2023-02-13 4:16 pm Purchase | 2023-02-08 | 13D | Spruce Biosciences, Inc. SPRB | HealthCap VIII, L.P. | 49,142 8.900% | 22,027 (+81.23%) | Filing History |
| 2022-09-30 4:54 pm Unchanged | 2022-09-27 | 13D | Spruce Biosciences, Inc. SPRB | Novo Holdings A/S | 60,191 19.200% | 0 (Unchanged) | Filing History |
| 2022-08-11 4:50 pm Purchase | 2022-08-01 | 13D | Spruce Biosciences, Inc. SPRB | Carlyle Group Inc. CG | 24,034 7.700% | 24,034 (New Position) | Filing History |
| 2022-02-14 6:24 pm Sale | 2021-12-31 | 13G | Spruce Biosciences, Inc. SPRB | Rock Springs Capital Management LP | 21,636 6.920% | -111 (-0.51%) | Filing History |
| 2022-02-14 06:12 am Purchase | 2021-12-31 | 13G | Spruce Biosciences, Inc. SPRB | Citadel Advisors LLC | 23,134 7.400% | 444 (+1.96%) | Filing History |
| 2022-02-11 4:21 pm Sale | 2021-12-31 | 13G | Spruce Biosciences, Inc. SPRB | Deerfield Mgmt, L.P. | 0 0.000% | -18,929 (Position Closed) | Filing History |
| 2022-02-09 10:01 am Sale | 2022-02-08 | 13G | Spruce Biosciences, Inc. SPRB | FMR LLC | 1,527 0.488% | -14,397 (-90.41%) | Filing History |
| 2021-11-22 4:08 pm Unchanged | 2021-11-08 | 13D | Spruce Biosciences, Inc. SPRB | Novo Holdings A/S | 60,191 19.200% | 0 (Unchanged) | Filing History |